INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $77,000 | -37.9% | 34,444 | -5.0% | 0.00% | – |
| Q3 2021 | $124,000 | -11.4% | 36,244 | -22.8% | 0.00% | – |
| Q2 2021 | $140,000 | +10.2% | 46,944 | +19.8% | 0.00% | – |
| Q1 2021 | $127,000 | +53.0% | 39,200 | 0.0% | 0.00% | – |
| Q4 2020 | $83,000 | +80.4% | 39,200 | 0.0% | 0.00% | – |
| Q3 2020 | $46,000 | +31.4% | 39,200 | 0.0% | 0.00% | – |
| Q2 2020 | $35,000 | -65.3% | 39,200 | -67.4% | 0.00% | – |
| Q1 2020 | $101,000 | -12.2% | 120,206 | 0.0% | 0.00% | – |
| Q4 2019 | $115,000 | -7.3% | 120,206 | 0.0% | 0.00% | – |
| Q3 2019 | $124,000 | -42.6% | 120,206 | 0.0% | 0.00% | – |
| Q2 2019 | $216,000 | -4.4% | 120,206 | 0.0% | 0.00% | – |
| Q1 2019 | $226,000 | +59.2% | 120,206 | 0.0% | 0.00% | – |
| Q4 2018 | $142,000 | -56.4% | 120,206 | 0.0% | 0.00% | – |
| Q3 2018 | $326,000 | +41.7% | 120,206 | 0.0% | 0.00% | – |
| Q2 2018 | $230,000 | +42.0% | 120,206 | +56.3% | 0.00% | – |
| Q1 2018 | $162,000 | -64.1% | 76,906 | -65.4% | 0.00% | – |
| Q4 2017 | $451,000 | +26.7% | 222,060 | -17.0% | 0.00% | – |
| Q3 2017 | $356,000 | -15.2% | 267,460 | 0.0% | 0.00% | – |
| Q2 2017 | $420,000 | -51.4% | 267,460 | -0.1% | 0.00% | – |
| Q1 2017 | $864,000 | +125.6% | 267,595 | -5.6% | 0.00% | – |
| Q4 2016 | $383,000 | -13.5% | 283,595 | -0.1% | 0.00% | – |
| Q3 2016 | $443,000 | +201.4% | 283,960 | +156.7% | 0.00% | – |
| Q2 2016 | $147,000 | -92.9% | 110,600 | -71.8% | 0.00% | – |
| Q1 2016 | $2,070,000 | -57.0% | 392,860 | -36.0% | 0.00% | -100.0% |
| Q4 2015 | $4,818,000 | -11.3% | 613,720 | -4.6% | 0.00% | 0.0% |
| Q3 2015 | $5,434,000 | -21.4% | 643,120 | +1.9% | 0.00% | 0.0% |
| Q2 2015 | $6,913,000 | -20.6% | 631,320 | +1.4% | 0.00% | -50.0% |
| Q1 2015 | $8,706,000 | -42.2% | 622,720 | -30.2% | 0.00% | -33.3% |
| Q4 2014 | $15,067,000 | +9.5% | 892,070 | -13.0% | 0.00% | 0.0% |
| Q3 2014 | $13,758,000 | +73.5% | 1,025,220 | +64.7% | 0.00% | +50.0% |
| Q2 2014 | $7,931,000 | +8.2% | 622,520 | +1.0% | 0.00% | 0.0% |
| Q1 2014 | $7,327,000 | -56.5% | 616,220 | -49.5% | 0.00% | 0.0% |
| Q4 2013 | $16,862,000 | -69.5% | 1,221,040 | -61.5% | 0.00% | -85.7% |
| Q3 2013 | $55,359,000 | -47.7% | 3,172,416 | -51.3% | 0.01% | 0.0% |
| Q2 2013 | $105,846,000 | – | 6,513,632 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
| Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
| Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
| Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
| Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
| Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
| Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |